Bioanalysis volume 9, issue 22


Issue 22 of Bioanalysis volume 9 is now available, including an editorial article on immunogenicity and biomarkers, a conference report from the 8th Japan Bioanalysis Forum and the 2017 White Paper on Recent issues in Bioanalysis. Explore the latest issue below, or head to the Bioanalysis webpage to find out more.

Conference report
The 8th Japan Bioanalysis Forum (JBF) symposium

Editorial
Immunogenicity and biomarkers: bioanalytical challenges and considerations

Interested in immunogenicity? Find out more in our article entitled overview of clinical immunogenicity: whys and wherefores and our quick-fire interview on immunogenicity with Mohsen Rajabi (FDA).

Methodology
Enantioselective supercritical fluid chromatography–tandem mass    spectrometry method for simultaneous estimation of risperidone and its 9-hydroxyl metabolites in rat plasma
A sensitive and accurate method to simultaneously measure uric acid and creatinine in human saliva by using LC–MS/MS
Volumetric absorptive microsampling combined with impact-assisted extraction for hematocrit effect free assays

Preliminary communication
Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine

Research article
A highly selective and sensitive LC–MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers

White Paper
2017 White Paper on Recent issues in Bioanalysis: Aren’t BMV guidance/guidelines ‘Scientific’? (Part 1 – LCMS: small molecules, peptides and small molecule biomarkers)

Review
Current practices and future outlook on the integration of biomarkers in the drug development process